Whales with a lot of money to spend have taken a noticeably bullish stance on Novo Nordisk.
Looking at options history for Novo Nordisk (NYSE:NVO) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 62% of the investors opened trades with bullish expectations and 37% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $83,110 and 6, calls, for a total amount of $233,083.
Expected Price Movements
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $40.0 to $120.0 for Novo Nordisk during the past quarter.
Insights into Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Novo Nordisk's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Novo Nordisk's whale activity within a strike price range from $40.0 to $120.0 in the last 30 days.
Novo Nordisk Option Activity Analysis: Last 30 Days

Significant Options Trades Detected:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
---|
NVO | CALL | TRADE | NEUTRAL | 01/16/26 | $120.00 | $51.8K | 133 | 32 |
NVO | CALL | SWEEP | BULLISH | 01/19/24 | $87.50 | $49.0K | 970 | 30 |
NVO | PUT | SWEEP | BULLISH | 02/16/24 | $115.00 | $45.1K | 35 | 56 |
NVO | CALL | SWEEP | BEARISH | 01/17/25 | $40.00 | $40.4K | 70 | 16 |
NVO | PUT | TRADE | BULLISH | 01/16/26 | $105.00 | $37.9K | 11 | 26 |
About Novo Nordisk
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Following our analysis of the options activities associated with Novo Nordisk, we pivot to a closer look at the company's own performance.
Current Position of Novo Nordisk
- With a trading volume of 1,321,941, the price of NVO is down by -0.1%, reaching $106.24.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 14 days from now.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Novo Nordisk, Benzinga Pro gives you real-time options trades alerts.
有大量資金可以花的大戶對諾和諾德採取了明顯的看漲立場。
查看諾和諾德(紐約證券交易所代碼:NVO)的期權歷史記錄,我們發現了8筆交易。
如果我們考慮每筆交易的具體情況,可以準確地說,62%的投資者以看漲的預期開啓交易,37%的投資者持看跌預期。
在已發現的全部交易中,有2筆是看跌期權,總額爲83,110美元;6筆看漲期權,總額爲233,083美元。
預期的價格走勢
分析這些合約的交易量和未平倉合約,看來大型企業一直在關注諾和諾德在過去一個季度的價格範圍從40.0美元到120.0美元不等。
對交易量和未平倉合約的見解
查看交易量和未平倉合約是對股票進行盡職調查的一種有見地的方式。
這些數據可以幫助您跟蹤Novo Nordisk期權在給定行使價下的流動性和利息。
下面,我們可以分別觀察過去30天內諾和諾德所有大戶活動的看漲和看跌期權交易量和未平倉合約的變化,其行使價在40.0美元至120.0美元之間。
諾和諾德期權活動分析:過去 30 天
檢測到的重大期權交易:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
---|
NVO | CALL | TRADE | NEUTRAL | 01/16/26 | $120.00 | $51.8K | 133 | 32 |
NVO | CALL | SWEEP | BULLISH | 01/19/24 | $87.50 | $49.0K | 970 | 30 |
NVO | PUT | SWEEP | BULLISH | 02/16/24 | $115.00 | $45.1K | 35 | 56 |
NVO | CALL | SWEEP | BEARISH | 01/17/25 | $40.00 | $40.4K | 70 | 16 |
NVO | PUT | TRADE | BULLISH | 01/16/26 | $105.00 | $37.9K | 11 | 26 |
關於 Novo Nordisk
Novo Nordisk擁有全球品牌糖尿病治療市場約三分之一的份額,是全球領先的糖尿病護理產品提供商。該公司總部位於丹麥,生產和銷售各種人類和現代胰島素、可注射的糖尿病治療藥物,例如 GLP-1 療法、口服抗糖尿病藥物和肥胖療法。Novo還有一個生物製藥板塊(約佔收入的10%),專門從事血友病和其他疾病的蛋白質療法。
在分析了與Novo Nordisk相關的期權活動之後,我們將轉向仔細研究公司自身的表現。
諾和諾德的當前位置
與僅交易股票相比,期權是一種風險更高的資產,但它們具有更高的盈利潛力。嚴肅的期權交易者通過每天進行自我教育、擴大交易規模、遵循多個指標以及密切關注市場來管理這種風險。
如果您想隨時了解Novo Nordisk的最新期權交易,Benzinga Pro會爲您提供實時期權交易提醒。